Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003132652 | SCV003808811 | uncertain significance | Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV005377338 | SCV006032688 | uncertain significance | Inborn genetic diseases | 2025-02-26 | criteria provided, single submitter | clinical testing | The c.2137G>A (p.E713K) alteration is located in exon 19 (coding exon 19) of the MIPEP gene. This alteration results from a G to A substitution at nucleotide position 2137, causing the glutamic acid (E) at amino acid position 713 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |